Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CRD vs Metformin in PCOS
NCT06049186Recruiting
- Sponsor
- Shanghai First Maternal and Infant Health Hospital
- Start
- Sep 2023
- Primary completion
- Jan 2026
- Countries
- 1
01
Overview
Randomised, open-label trial (2 arms), sponsored by Shanghai First Maternal and Infant Health Hospital. Primary endpoint: Live birth during the period of ovulation induction at 18 months. Started Sep 2023; status: recruiting.
Beyond the preview
Go deeper on NCT06049186.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06049186.